Why the study?
To investigate the efficacy and safety of deep versus moderate neuromuscular block in patients undergoing bariatric surgery.
Does deep neuromuscular block improve surgical field quality and reduce pain in patients undergoing bariatric surgery compared to moderate neuromuscular block?
Does deep neuromuscular block improve surgical field quality and reduce pain in patients undergoing bariatric surgery compared to moderate neuromuscular block?
Deep neuromuscular block may improve surgical field quality and reduce postoperative pain in bariatric surgery, though the evidence quality is very low.
Answers are grounded in this paper and cite their sources.
Deep NMB may improve surgical conditions in bariatric surgery; extends limited RCT data but leaves optimal use open.
This systematic review and meta-analysis were designed to investigate the efficacy and safety of deep (DNMB) versus moderate (MNMB) neuromuscular block on the treatment of patients submitted to bariatric surgery. Randomized controlled trials (RCTs) were searched from inception to December 2017 in the following databases: PubMed, EMBASE, COCHRANE, Scopus, Web of Science and LILACS. Reviewers independently screened potentially eligible articles, extracted data from included studies and assessed their risk of bias. We used the GRADE approach to rate overall certainty of the evidence for each outcome. Two RCTs including 160 participants proved eligible, and their results yielded a statistically significant improvement on surgical field quality according to the Leiden-Surgical Rating Scale (L-SRS) with the use of DNMB compared to MNMB (MD 0.57, 95% CI 0.39 to 0.75; participants = 160; studies = 2; I2 = 16%; p < 0.00001). Results from one RCT yielded a statistically significant reduction in pain scores at the post-anesthesia care unit (MD -0.50, 95% CI -0.71 to -0.29; participants = 100; studies = 1; p < 0.00001) and in referred shoulder pain at the surgical ward (MD -0.50, 95% CI -0.64 to -0.36; participants = 100; studies = 1; p < 0.00001) with the use of DNMB compared to MNMB. There was no increase in adverse outcomes detected. The quality of evidence was rated as very-low for both outcomes.
No takes yet. Share an insight, caveat, or question.
Pereira et al. (2019) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: